BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 21851899)

  • 21. The routine use of surgical exposure approach for trans-femoral implantation of the balloon expandable aortic prosthesis is associated to a low rate of vascular complications.
    DE LA Torre Hernandez JM; Moreno R; Lee DH; Garcia Del Blanco B; Sanmartin JC; Garcia Blas S; Serra Garcia V; Gaviria K; Garcia I; Zueco J
    J Cardiovasc Surg (Torino); 2016 Aug; 57(4):615-9. PubMed ID: 25673098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Propensity-matched comparison between Direct Flow Medical, Medtronic Corevalve, and Edwards Sapien XT prostheses: Device success, thirty-day safety, and mortality.
    Zhang Y; Pyxaras SA; Wolf A; Schmitz T; Naber CK
    Catheter Cardiovasc Interv; 2015 Jun; 85(7):1217-25. PubMed ID: 25581785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes after transfemoral transcatheter aortic valve replacement: a comparison of the randomized PARTNER (Placement of AoRTic TraNscathetER Valves) trial with the NRCA (Nonrandomized Continued Access) registry.
    Fearon WF; Kodali S; Doshi D; Fischbein MP; Yeung AC; Tuzcu EM; Rihal CS; Babaliaros V; Zajarias A; Herrmann HC; Brown DL; Mack M; Teirstein PS; Whisenant BK; Makkar R; Kapadia S; Leon MB;
    JACC Cardiovasc Interv; 2014 Nov; 7(11):1245-51. PubMed ID: 25459036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A modified "preclosure" technique after percutaneous aortic valve replacement.
    Kahlert P; Eggebrecht H; Erbel R; Sack S
    Catheter Cardiovasc Interv; 2008 Nov; 72(6):877-84. PubMed ID: 19006257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vascular complications in steroid treated patients undergoing transfemoral aortic valve implantation.
    Fink N; Segev A; Barbash I; Bogdan A; Hamdan A; Mazin I; Maor E; Hay I; Guetta V; Fefer P
    Catheter Cardiovasc Interv; 2016 Feb; 87(2):341-6. PubMed ID: 26010839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A simple percutaneous technique for hemostasis and closure after transcatheter aortic valve implantation.
    Badawi RA; Collins TJ; Ramee SR
    Catheter Cardiovasc Interv; 2012 Jan; 79(1):152-5. PubMed ID: 21990123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complications of the access during aortic valve implantation through transfemoral access.
    Alsac JM; Zegdi R; Blanchard D; Achouh P; Cholley B; Berrebi A; Julia P; Fabiani JN
    Ann Vasc Surg; 2011 Aug; 25(6):752-7. PubMed ID: 21621377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence, predictors and impact of bleeding after transcatheter aortic valve implantation using the balloon-expandable Edwards prosthesis.
    Borz B; Durand E; Godin M; Tron C; Canville A; Litzler PY; Bessou JP; Cribier A; Eltchaninoff H
    Heart; 2013 Jun; 99(12):860-5. PubMed ID: 23236027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence and prognosis of vascular complications after transcatheter aortic valve implantation.
    Mwipatayi BP; Picardo A; Masilonyane-Jones TV; Larbalestier R; Thomas S; Turner J; Vijayan V; Yong G
    J Vasc Surg; 2013 Oct; 58(4):1028-36.e1. PubMed ID: 23993436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. European experience with the second-generation Edwards SAPIEN XT transcatheter heart valve in patients with severe aortic stenosis: 1-year outcomes from the SOURCE XT Registry.
    Schymik G; Lefèvre T; Bartorelli AL; Rubino P; Treede H; Walther T; Baumgartner H; Windecker S; Wendler O; Urban P; Mandinov L; Thomas M; Vahanian A
    JACC Cardiovasc Interv; 2015 Apr; 8(5):657-69. PubMed ID: 25946437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes of transcatheter aortic valve replacement in patients with chronic liver disease.
    Shah AM; Ogbara J; Herrmann HC; Fox Z; Kadakia M; Anwaruddin S; Bavaria JE; Desai ND; Jagasia D; Szeto WY; Li RH; Vallabhajosyula P; Giri J
    Catheter Cardiovasc Interv; 2015 Nov; 86(5):888-94. PubMed ID: 25963625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early clinical outcome of aortic transcatheter valve-in-valve implantation in the Nordic countries.
    Ihlberg L; Nissen H; Nielsen NE; Rück A; Busund R; Klaarborg KE; Soendergaard L; Harnek J; Miettinen H; Eskola M; Wahba A; Laine M
    J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1047-54; discussion 1054. PubMed ID: 23998786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized trial of surgical cutdown versus percutaneous access in transfemoral TAVR.
    Holper EM; Kim RJ; Mack M; Brown D; Brinkman W; Herbert M; Stewart W; Vance K; Bowers B; Dewey T
    Catheter Cardiovasc Interv; 2014 Feb; 83(3):457-64. PubMed ID: 23703878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of severe left ventricular systolic dysfunction on hospital outcome after transcatheter aortic valve implantation or surgical aortic valve replacement: results from a propensity-matched population of the Italian OBSERVANT multicenter study.
    Onorati F; D'Errigo P; Grossi C; Barbanti M; Ranucci M; Covello DR; Rosato S; Maraschini A; Santoro G; Tamburino C; Seccareccia F; Santini F; Menicanti L;
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):568-75. PubMed ID: 24263007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of femoral artery puncture using digital subtraction angiography and road mapping on vascular and bleeding complications after transfemoral transcatheter aortic valve implantation.
    El-Mawardy M; Schwarz B; Landt M; Sulimov D; Kebernik J; Allali A; Becker B; Toelg R; Richardt G; Abdel-Wahab M
    EuroIntervention; 2017 Jan; 12(13):1667-1673. PubMed ID: 28106001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surgical cut-down or percutaneous access-which is best for less vascular access complications in transfemoral TAVI?
    Spitzer SG; Wilbring M; Alexiou K; Stumpf J; Kappert U; Matschke K
    Catheter Cardiovasc Interv; 2016 Aug; 88(2):E52-8. PubMed ID: 26708225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful use of a left ventricular apical access and closure device for second-generation transapical aortic valve implantation.
    Conradi L; Seiffert M; Shimamura K; Schirmer J; Blankenberg S; Reichenspurner H; Diemert P; Treede H
    Thorac Cardiovasc Surg; 2014 Sep; 62(6):498-502. PubMed ID: 24911901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcarotid Transcatheter Aortic Valve Replacement: Feasibility and Safety.
    Mylotte D; Sudre A; Teiger E; Obadia JF; Lee M; Spence M; Khamis H; Al Nooryani A; Delhaye C; Amr G; Koussa M; Debry N; Piazza N; Modine T
    JACC Cardiovasc Interv; 2016 Mar; 9(5):472-80. PubMed ID: 26965937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bleeding complications after surgical aortic valve replacement compared with transcatheter aortic valve replacement: insights from the PARTNER I Trial (Placement of Aortic Transcatheter Valve).
    Généreux P; Cohen DJ; Williams MR; Mack M; Kodali SK; Svensson LG; Kirtane AJ; Xu K; McAndrew TC; Makkar R; Smith CR; Leon MB
    J Am Coll Cardiol; 2014 Mar; 63(11):1100-9. PubMed ID: 24291283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expandable sheath for transfemoral transcatheter aortic valve replacement: procedural outcomes and complications.
    Borz B; Durand E; Tron C; Godin M; Canville A; Hauville C; Cribier A; Eltchaninoff H
    Catheter Cardiovasc Interv; 2014 May; 83(6):E227-32. PubMed ID: 24403004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.